Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

BACKGROUND: The risk of tuberculosis (TB) in patients with rheumatoid arthritis (RA) is thought to be increased following anti-tumour necrosis factor (anti-TNF) therapy, with a proposed differential risk between the anti-TNF drugs etanercept (ETA), infliximab (INF) and adalimumab (ADA). OBJECTIVE: T...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Dixon, W G, Hyrich, K L, Watson, K D, Lunt, M, Galloway, J, Ustianowski, A, Symmons, D P M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2009
Gaiak:
Clinical and Epidemiological Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2927681/
https://ncbi.nlm.nih.gov/pubmed/19854715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2009.118935
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak